<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03424590</url>
  </required_header>
  <id_info>
    <org_study_id>PROTOCOL-0987</org_study_id>
    <nct_id>NCT03424590</nct_id>
  </id_info>
  <brief_title>Connected Ovulation Test Efficacy Study</brief_title>
  <official_title>Libera Efficacy 2 Cycles at Home Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SPD Development Company Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SPD Development Company Limited</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clearblue Connected Ovulation Test System (COTS) has been designed for home use by women who&#xD;
      are either planning or trying for a pregnancy. This study will determine the difference in&#xD;
      pregnancy rate of female volunteers seeking to get pregnant who use COTS in comparison to&#xD;
      those not using an ovulation product to assist with conception.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 29, 2018</start_date>
  <completion_date type="Actual">September 19, 2018</completion_date>
  <primary_completion_date type="Actual">September 19, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in pregnancy rates across 2 cycles of use between volunteers trying to conceive in the home setting using (i) COTS, (ii) no intervention.</measure>
    <time_frame>2 months</time_frame>
    <description>The difference in pregnancy rates between volunteers trying to conceive in the home setting using (i) COTS (ii) no intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of behaviour of women trying to conceive</measure>
    <time_frame>2 months</time_frame>
    <description>Quantitative assessment in methods used to try and help with conception and intercourse patterns.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of women's experience of trying to conceive using COTS compared to not using ovulation tests</measure>
    <time_frame>2 months</time_frame>
    <description>Qualitative interview responses regarding usage and experience of COTS or other methods whilst trying to conceive.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1000</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>COTS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Volunteers will be provided with Clearblue connected Ovulation test system to use during the study period, accortding to the instructions for use.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Volunteers will not be provided with Clearblue Connected Ovulation Test System and will be instructed not to use any other ovulation predictions tests during the study period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Clearblue Connected Ovulation Test System</intervention_name>
    <description>Urinary LH test to predict ovulation</description>
    <arm_group_label>COTS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Actively trying to conceive&#xD;
&#xD;
          -  At least 2 regular consecutive cycles since last pregnancy/ miscarriage/ or since&#xD;
             stopping breastfeeding&#xD;
&#xD;
          -  Willing to use their own smartphone for the duration of this study and to download and&#xD;
             install the study app&#xD;
&#xD;
          -  Willing to disclose their pregnancy status and provide urine samples to test markers&#xD;
             related to pregnancy and fertility&#xD;
&#xD;
          -  Have internet access on their phone for the duration of the study&#xD;
&#xD;
          -  Willing to give informed consent and comply with the investigational procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently or previously employed by SPD, Alere, Abbott, Unipath or P&amp;G, or affiliates&#xD;
&#xD;
          -  Has an immediate relative* currently or previously employed by SPD, Alere, Abbott,&#xD;
             Unipath or P&amp;G or affiliates&#xD;
&#xD;
          -  There is a reason why the volunteer should not get pregnant e.g. they are taking a&#xD;
             medication or have a medical condition which means they should not get pregnant&#xD;
&#xD;
          -  Trying to conceive for more than 6 months (if less than 35 years old) and more than 3&#xD;
             months (if 35 years old or over)&#xD;
&#xD;
          -  Has been diagnosed with Polycystic Ovarian Syndrome (PCOS)&#xD;
&#xD;
          -  Has PCOS symptoms: very irregular cycles, hirsutism&#xD;
&#xD;
          -  Using or has previously used infertility medications or hormone replacement therapy&#xD;
             containing hCG or LH (e.g Pregnyl)&#xD;
&#xD;
          -  Are taking clomiphene citrate or other ovulation induction drugs&#xD;
&#xD;
          -  Using any treatment which may affect the menstrual cycle (e.g. the contraceptive pill)&#xD;
&#xD;
          -  Currently pregnant or breastfeeding&#xD;
&#xD;
          -  Peri- or post-menopausal, e.g. experiencing symptoms: Irregular menstrual periods, hot&#xD;
             flushes, night sweats, sleep disturbances, and mood swings&#xD;
&#xD;
          -  Have abnormal liver or kidney function&#xD;
&#xD;
          -  Taking medication containing tetracycline&#xD;
&#xD;
          -  Using or undergoing any other medical treatment for fertility such as ovulation drugs,&#xD;
             artificial insemination and assisted fertility such as IVF or ICSI&#xD;
&#xD;
          -  Has a phone that is known to be incompatible with COTS&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Johnson, Dr</last_name>
    <role>Study Director</role>
    <affiliation>SPD Development Company Ltd.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SPD Development Company Ltd</name>
      <address>
        <city>Bedford</city>
        <state>Bedfordshire</state>
        <zip>MK44 3UP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>January 25, 2018</study_first_submitted>
  <study_first_submitted_qc>January 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 7, 2018</study_first_posted>
  <last_update_submitted>October 18, 2018</last_update_submitted>
  <last_update_submitted_qc>October 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

